Zeon Invests in Company Developing Cancer Therapy on February 3, 2025 in Industry Zeon has invested in Optieum Biotechnologies, a developer of innovative CAR T cells. Optieum is aiming to commercialize the world’s…... Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here Continue Reading
